Annual Drug Patent Expirations for TAVNEOS
Tavneos is a drug marketed by Chemocentryx and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
This drug has sixty-six patent family members in thirty-five countries.
The generic ingredient in TAVNEOS is avacopan. One supplier is listed for this compound. Additional details are available on the avacopan profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
